Correvio Pharma Corp.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Correvio Pharma Corp.
Pieris and Genentech try partnering again after a disappointing IO tie-up before. Biogen’s hectic May includes partnerships with Ginkgo, Envisagenics, Capsigen and an opt-in on TMS’s stroke candidate.
Schizophrenia drug licensed from Takeda missed Phase II endpoint for negative symptoms, but hits secondary cognition endpoints. Neurocrine plans to further study compound for cognitive benefits.
The Madrid, Spain-based company is developing the AblaView ablation catheter for treating atrial fibrillation.
With $1.1bn in cash plus revenue from its existing commercial products and royalties from Roche’s sales of newly approved Evrysdi to invest in R&D, PTC Therapeutics may achieve profitability in 2023.
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
- ADVANZ PHARMA Corp. Limited
- Cardiome Pharma Corp. (CRME)
- Cardiome Development AG
- Correvio LLC (Iroko Cardio LLC)